CERO TERAPEUTICS HLDG INC by CERo Therapeutics Holdings, Inc. Financials - Benzinga

CERO TERAPEUTICS HLDG INC by CERo Therapeutics Holdings, Inc.

CEROOTCQB

Trade with Public

Trade with Public

$0.0951

-1.69-94.69%

At close: Oct 29, 5:00 PM EST

$0.0330

-1.76-98.16%

Pre-Market: 5:00 PM EST

Overview News Earnings Forecast Events Price TargetsFinancialsSentiment Ownership Compare

CERO TERAPEUTICS HLDG INC by CERo Therapeutics Holdings, Inc. Financials

CERO TERAPEUTICS HLDG INC by CERo Therapeutics Holdings, Inc. (CERO) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
CERo Therapeutics Hldgs Q1 EPS $(0.20) Beats $(1.00) Estimate

CERo Therapeutics Hldgs (OTC:CERO) reported quarterly losses of $(0.20) per share which beat the analyst consensus estimate of $(1.00) by 80 percent. This is a 99.37 percent increase over losses of $(31.80) per share

Benzinga Newsdesk

PRO
CERo Therapeutics Hldgs Q3 EPS $(9.10) Misses $(2.94) Estimate

CERo Therapeutics Hldgs (NASDAQ:CERO) reported quarterly losses of $(9.10) per share which missed the analyst consensus estimate of $(2.94) by 210.05 percent. This is a 94.65 percent increase over losses of $(170.22) per

Benzinga Newsdesk

Nasdaq Falls Over 1%; Alphabet Posts Upbeat Earnings

Avi Kapoor

PRO
CERo Therapeutics Hldgs Q2 EPS $(61.71) Misses $(11.21) Estimate

CERo Therapeutics Hldgs (NASDAQ:CERO) reported quarterly losses of $(61.71) per share which missed the analyst consensus estimate of $(11.21) by 450.74 percent. This is a 79.59 percent increase over losses of $(302.32)

Benzinga Newsdesk

Dow Surges 150 Points; Korn Ferry Earnings Top Views

Avi Kapoor

Crude Oil Rises Sharply; Jabil Earnings Top Views

Avi Kapoor